Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: A comparison between two different daily doses of lansoprazole

Table 4 Patient symptoms evaluated at baseline (visit 1), after the PPI test (visit 2) and at the end of the 12-week lansoprazole treatment period (visit 3)

	Visit 1		Visit 2		Visit 3
	VAS	Score	VAS	Score	VAS	Score
Lansoprazole	8 (7.5-9.5)	9 (8-9)	2 (1.5-5.5)b	4 (3-7)a	1 (0-4.5)b	3 (0-6.5)b
(30 mg/d)
(n = 17)
Lansoprazole	9 (8-9)	8 (7-9)	2 (1-6.5)b	3.5 (3-7)a	1 (0-5)b	3 (0-6.25)b
(60 mg/d)
(n = 18)

Data expressed as median (25%-75% quartiles).

^bP < 0.001 vs visit 1;

^aP < 0.005 vs visit 1.